Open Investments – WHA Rights Issue

Wattle Health Rights Issue

This Offer Is Now Closed

Rights Issue Details

Offer Price*

$0.15c

*Previous institutional offer price. All applications and monies must be received by 5.00pm AEST Monday, 21 June 2021.

As Wattle Health Australia (WHA) looks to rebrand as Wellnex Life (WNX) I believe the company is well-positioned to capitalise on the multi-billion-dollar health & wellness sector. We have a pathway to ongoing profitability in an industry that’s growing locally and globally, and the right capital structure and management team in place to take full advantage of future opportunities for Wellnex Life.

George Karafotias, CFO

Speak to an Advisor

What is a 708 investor?

By submitting this form, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach are engaged as a Corporate Advisor to WHA. As the advisers assisting with the management of the offer, Reach may receive fees depending on its uptake.

Offer Details

Wattle Health Australia is proposing a non-renounceable rights issue offer (Entitlement Offer) of subscribing for 1 new Share for every 12 Shares held by shareholders holding Shares on Tuesday, 18 May 2021 (Record Date), together with a right to subscribe for additional Shares.

Use of Funds

The funds raised under the Entitlement Offer will be used:

  • For the purpose of the rights issue, to expand on current business opportunities; and
  • General working capital

Whilst providing shareholders the opportunity to participate at the same price as the c-note holders and the last institutional offering.

Wattle Health Rights Issue

Offer Price*

$0.15c

*Previous institutional offer price. All applications and monies must be received by 5.00pm (AEST) Monday, 21 June 2021. To participate, click here to have your personal rights issue form emailed to you

Company Presentation

Investor Presentation

A New Path Forward

“As Wattle Health Australia (WHA) looks to rebrand as Wellnex Life (WNX) I believe the company is well-positioned to capitalise on the multi-billion-dollar health & wellness sector. We have a pathway to ongoing profitability in an industry that’s growing locally and globally, and the right capital structure and management team in place to take full advantage of future opportunities for Wellnex Life.”

George Karafotias – CEO

Speak to an Advisor

What is a 708 investor?

By submitting this form, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach are engaged as a Corporate Advisor to WHA. As the advisers assisting with the management of the offer, Reach may receive fees depending on its uptake.